Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 2015

View Archived Issues

New data presented on the use of [18F]AV14151 as a tau PET tracer

Rigel Pharmaceuticals reviews development pipeline

Phase II data on the coadministration of VT-122 and sorafenib to HCC patients reported

Famitinib improves progression-free survival in CRC patients

Pilot study investigates imaging markers to guide PBT-2 development

Final results of phase I/II study of ISIS-183750 plus irinotecan

Johnson & Johnson reviews progress of fourth quarter 2014

Trovagene and Genomac Research Institute to collaborate on cancer drug resistance prediction trials

Endonovo Therapeutics agrees on equity investment

Athersys and Cell Therapy Catapult receive stem cell therapy grants for acute respiratory condition

Japan Tobacco divulges PDHK inhibitors

Forendo Pharma reports development of 17beta-HSD1 inhibitors

Merck KGaA prepares positive allosteric modulators for infertility

Sichuan Haisco Pharmaceutical presents SGLT2 inhibitors for diabetes

Alligator Bioscience discloses polypeptides binding to CTLA-4 for cancer

FDA grants orphan drug status to intracerebral hemorrhage treatment

APR-246 receives European orphan drug designation

Human abuse liability study of Egalet meets primary endpoint

GSK ships Ebola vaccine candidate to Liberia for phase III trial

FDA clears IND for phase I study of ADXS-HER2

FDA advisory committee recommends approval of Cresemba

Heptares and AstraZeneca advance drug discovery collaboration

Alexza Pharmaceuticals initiates phase II trial of inhaled alprazolam in epilepsy

Sigma-Aldrich and VIB form alliance to supply translational research tools and technologies

Ultimovacs completes share issue to fund development of cancer vaccine UV-1

CytRx reports results from phase IIb trial of aldoxorubicin in soft tissue sarcoma

CHMP issues positive opinion for Prevenar 13 for prevention of pneumococcal pneumonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...